Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Recombinant Human CD3 zeta Protein
SDP

Catalog No. NBP26146220 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μg
20 μg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP26146220 20 μg
NB261462100 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. NBP26146220 Supplier Novus Biologicals™ Supplier No. NBP26146220UG
Only null left
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results. Applications: SDS-Page

A recombinant protein with a C-terminal His-tag and corresponding to the amino acids 52-164 of Human CD3. The Recombinant Human CD3 zeta Protein is derived from Baculovirus. The Recombinant Human CD3 zeta Protein has been validated for the following applications: SDS-Page.

Specifications

Concentration 0.2 mg/ml
For Use With (Application) SDS-PAGE
Formulation 20mM Tris-HCl buffer (pH 6.8) containing 50% glycerol, 1mM DTT, 1mM EDTA, 0.1M NaCl
Gene ID (Entrez) 919
Molecular Weight (g/mol) 14.1 kDa
Quantity 20 μg
Source Baculovirus
Storage Requirements Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Regulatory Status RUO
Endotoxin Concentration < 1.0 EU per 1μg of protein (determined by LAL method)
Gene Symbol CD247
Cross Reactivity CD3 zeta
Species Human
Purity or Quality Grade >90%, by SDS-PAGE
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.